Photo via Fox News

Pro-life group says Trump admin didn't give key abortion drug commitments before Overton FDA nomination pulled

Read the original at Fox News ↗
Cite

Mion, L. (2026, November 20). Pro-life group says Trump admin didn't give key abortion drug commitments before Overton FDA nomination pulled. Fox News. https://www.foxnews.com/politics/pro-life-group-says-trump-admin-didnt-give-key-abortion-drug-commitments-overton-fda-nomination-pulled

Dated from the outlet's own feed. Check the original for its byline.

Fox News · collected 2026-11-20 · by Landon Mion

Quick Summary

Erik Baptist, senior vice president of legal strategy at Susan B. Anthony Pro-Life America, told Fox News Digital that his organization pushed for the Senate to delay Heidi Overton's nomination to head the FDA until the Trump administration committed to ending mail-order access to abortion drugs and changing how the FDA studies the safety of those drugs. Baptist emphasized that pro-life states cannot enforce their laws while the current nationwide policy remains in place, citing instances where men and predators obtain abortion drugs to coerce or harm women. He also called for a new, more robust study on mifepristone’s safety.
Written by AI on 2026-11-20, from this article's own text only (the story summary below draws on all the coverage).
See how they differ ↓

AI analysis

Story summary

The White House withdrew Dr. Heidi Overton’s nomination to lead the Food and Drug Administration (FDA) on November 17, 2026, just before a scheduled Senate committee vote, due to lack of bipartisan support. Overton faced skepticism from some Republicans over her involvement in the administration's efforts to change childhood vaccine recommendations. To advance to the full Senate, Overton needed 11 votes from the 21-member committee, but she failed to secure the necessary Republican support. The decision leaves the FDA’s leadership vacancy unresolved, with Senate Democrats now likely to take the lead in selecting a new nominee.

Written for “White House Withdraws Heidi Overton’s FDA Nomination” on 2026-11-21, grounded in this article and the 16 other(s) covering the same event.

How they differ

13 outlets covered “White House Withdraws Heidi Overton’s FDA Nomination”.

What each outlet says

One AI summary per outlet of its latest article on this story, written from that article alone and checked against it. Open the article for the outlet's own words.

Fox NewsThis outlet20 Nov

Erik Baptist, senior vice president of legal strategy at Susan B. Anthony Pro-Life America, told Fox News Digital that his organization pushed for the Senate to delay Heidi Overton's nomination to head the FDA until the Trump administration committed to ending mail-order access to abortion drugs and changing how the FDA studies the safety of those drugs. Baptist emphasized that pro-life states cannot enforce their…

Pro-life group says Trump admin didn't give key abortion drug commitments before Overton FDA nomination pulled (this article)2 articles from Fox News on this story
Semafor19 Nov

The FDA is facing a leadership gap as the White House has withdrawn Heidi Overton's nomination, likely preventing a replacement before the end of the year. This situation could lead to a series of temporary commissioners, such as Sara Brenner or Karim Mikhail, overseeing the agency's operations. The lack of a permanent leader complicates efforts to secure industry user fees, which provide half of the FDA’s funding…

FDA's long-term vacancy →3 articles from Semafor on this story
CBS News18 Nov

The White House has withdrawn Dr. Heidi Overton's nomination as the new FDA commissioner, a position she was selected for by President Trump. The Senate health committee was set to vote on her nomination on Wednesday, but the White House has since decided to remove her from consideration. Axios was the first to report this change.

White House drops Heidi Overton's nomination for FDA commissioner →2 articles from CBS News on this story
New York Post18 Nov

The White House has withdrawn Heidi Overton’s nomination to lead the Food and Drug Administration (FDA) due to insufficient support from Senate lawmakers. Overton, a physician and deputy director of the White House Domestic Policy Council, faced significant opposition for her alleged ties to the tobacco industry, pro-vaping stance, and anti-abortion views. Critics demonstrated their disapproval by placing signs…

White House withdraws Heidi Overton’s FDA nomination after Trump pick received bipartisan pushback →
The Straits Times18 Nov

The White House has withdrawn Heidi Overton’s nomination to lead the US Food and Drug Administration (FDA) before her confirmation hearing, according to Axios. The decision was made due to a lack of congressional support, especially after criticism from a former Health Secretary’s adviser and opposition from several Republican senators. This move adds to the FDA’s ongoing leadership challenges, with the agency…

White House pulls FDA chief nominee Heidi Overton before hearing, Axios says →
Toronto Star18 Nov

The White House has withdrawn Dr. Heidi Overton’s nomination to lead the Food and Drug Administration due to insufficient Senate Republican support. Overton, a Trump-aligned physician and White House domestic policy adviser, was nominated in August to replace Dr. Marty Makary, who had a controversial tenure. Her nomination was intended to stabilize the FDA with a Trump loyalist, but faced opposition that prevented…

White House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans →
Show 7 more outlets
NBC News18 Nov

The White House has withdrawn Dr. Heidi Overton’s nomination to become the FDA commissioner due to Republican senators' concerns about her lack of managerial experience. The decision came shortly before Overton’s scheduled Senate Health Committee vote, where she needed at least one Republican vote to advance. Senators Cassidy, Collins, and Murkowski expressed reservations about Overton’s qualifications and her…

White House drops Heidi Overton’s FDA nomination →
ABC News (US)18 Nov

Dr. Heidi Overton's nomination to become the FDA commissioner was withdrawn on Tuesday after facing significant opposition from some Republican senators. The nomination encountered hurdles primarily due to Overton’s positions on abortion, vaccines, and vaping, according to sources familiar with the situation.

Trump's pick Heidi Overton dropped as nominee for FDA commissioner →
Just the News18 Nov

The White House has withdrawn Heidi Overton's nomination to lead the Food and Drug Administration (FDA) just one day before her scheduled vote by the Senate Health, Education, Labor and Pensions Committee. Overton, a physician and deputy director of the White House Domestic Policy Council, faced skepticism from some Republicans about her involvement in changing childhood vaccine recommendations. A senior…

White House pulls Heidi Overton's nomination to lead Food and Drug Administration: Report →
The Guardian18 Nov

The White House has withdrawn Heidi Overton’s nomination to lead the Food and Drug Administration after bipartisan concerns about her willingness to challenge President Trump’s policies, particularly regarding vaccines and abortion. Republican senator Bill Cassidy, who chairs the Senate health committee, had expressed reservations about her support for Trump’s vaccine plans and her stance on abortion rights…

White House withdraws nomination of Heidi Overton to lead FDA →
Daily Caller18 Nov

The Trump administration withdrew Heidi Overton’s nomination to lead the FDA on November 18, 2026, due to lack of support in the Senate. Overton, a physician and deputy director of the White House Domestic Policy Council, was nominated in August and faced opposition from Democrats, some Republicans, and MAHA activists. The White House cited the need for a more populist approach to health as the reason for the…

MAHA Rejoices After White House Drops Controversial FDA Nomination →
The Independent18 Nov

The White House has withdrawn Dr. Heidi Overton’s nomination to lead the Food and Drug Administration (FDA) just before a Senate committee vote scheduled for Wednesday. Overton, a physician with a history of opposing abortion, faced significant opposition from pro-life senators like Josh Hawley, as well as from senators like Susan Collins and Lisa Murkowski over her stance on abortion and her role in approving…

White House pulls Trump’s FDA nominee on eve of key Senate vote →

Where they agree and split

Framing

How the first headlines put it

Attributed to a source2
Stated as fact10
The headlines (12)

White House pulls FDA chief nominee Heidi Overton before hearing, Axios says The Straits Times · attributed to a source

White House pulls Heidi Overton's nomination to lead Food and Drug Administration: Report Just the News · attributed to a source

Trump administration weighs Marshall for FDA as Overton wobbles Semafor · stated as fact

Trump FDA nominee Heidi Overton struggling to win GOP support CBS News · stated as fact

White House withdraws Heidi Overton’s FDA nomination after Trump pick received bipartisan pushback New York Post · stated as fact

White House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans Toronto Star · stated as fact

White House drops Heidi Overton’s FDA nomination NBC News · stated as fact

White House pulls Trump’s FDA pick Heidi Overton on eve of Senate panel vote Fox News · stated as fact

Trump's pick Heidi Overton dropped as nominee for FDA commissioner ABC News · stated as fact

White House withdraws nomination of Heidi Overton to lead FDA The Guardian · stated as fact

White House withdraws Heidi Overton’s nomination to become next FDA commissioner Washington Examiner · stated as fact

MAHA Rejoices After White House Drops Controversial FDA Nomination Daily Caller · stated as fact

The full story: what happened, how it changed, and all 17 articles →

Compared with similar articles

This article reads unscored and hedges 8% of its claims. Each row says how that neighbour differs.
Semafor
Hedges 3 of 8 claims Outlet record 64/100
Toronto Star
Leans right Hedges 0 of 3 claims Outlet record 65/100
“The articles describe different aspects of the same general situation — Article A reports the withdrawal of Dr. Overton's nomination, while Article B discusses the pro-life group's stance and demands prior to the withdrawal.”
NBC News
Leans right Hedges 1 of 19 claims Outlet record 74/100
“While both articles discuss the withdrawal of Dr. Heidi Overton's FDA nomination, Article A focuses on the White House's decision and timing, while Article B focuses on a pro-life group's reaction and opposition to her nomination based on policy commitments. They describe different aspects of the same broader event but not the same specific incident.”
ABC News (US)
Leans right Hedges 0 of 4 claims Outlet record 66/100
Just The News
Hedges 2 of 10 claims Outlet record 59/100
CBS News
Leans right Hedges 3 of 33 claims Outlet record 66/100
“Article A discusses Overton's struggle to gain support for her nomination, while Article B reports on the withdrawal of her nomination after she failed to secure enough support, indicating these are two related but distinct events.”
The Straits Times
Hedges 3 of 17 claims Outlet record 64/100
“While both articles discuss the withdrawal of Heidi Overton's nomination to lead the FDA, Article B focuses on the reasons given by a pro-life group for opposing her nomination, which is a related but distinct event from the actual withdrawal itself.”
CBS News
Hedges 1 of 4 claims Outlet record 66/100
“While both articles discuss the withdrawal of Dr. Heidi Overton's nomination for FDA commissioner, Article B focuses on the reasons behind the decision from a pro-life group's perspective, suggesting it covers a related but distinct event or aspect rather than the same specific incident.”
Fox News
Leans strongly right Hedges 2 of 17 claims Outlet record 66/100
“While both articles discuss Dr. Heidi Overton's FDA nomination and commitments regarding abortion drug policy, they describe different aspects and outcomes of the event, with Article A focusing on the pro-life group's opposition and the withdrawal of the nomination, and Article B reporting on Overton's commitment to a safety review after pressure from Senator Hawley.”
Fox News
Hedges 0 of 1 claims Outlet record 66/100
“While both articles discuss the withdrawal of Heidi Overton's nomination, Article B provides additional context about a pro-life group's opposition and requests for policy commitments, indicating a related but distinct event.”

Story

White House Withdraws Heidi Overton’s FDA Nomination
Politics · 17 article(s) covering the same event. Compare every outlet's account →
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
48
sentences that state something as happening or true
Uncertain
8%
4 of 48 hedged ("reportedly", "may", "according to")
Leaning
withheld
no quote in the article backed the model's score
Publisher signals
66/100
Fox News's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
17
Politics
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-11-20 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Fox News · 8414 article(s) · 16 correction(s) detected
Running correction rate · 16 correction(s)

Who wrote this

Landon Mion
82 article(s) here · 1 carrying a prediction
"When I say anybody, we’ve seen news story after news story every week about men and other predators obtaining these drugs to coerce or poison women into taking them against their will.
Khanna, a frequent critic of President Donald Trump's war in the Middle East, said the checks would be sent to every American family to reimburse them for the higher gas, food and electricity prices sparked by the conflict and resulting disruptions to oil transport routes.
"Failure to do so may result in sanctions, adverse-inference instructions, or other penalties, and may carry significant legal consequences," Reitz added.
Middlebrook and McIntosh were taken into custody by Las Vegas Metro Police and booked into the Clark County Detention Center in Las Vegas, where they will be held until they can be extradited to Mohave County, Arizona.
Will they stay voting for Democrats in the future?
Delray Beach Mayor Tom Carney said he has received numerous messages and seen social media posts criticizing the decision to cancel the St. Patrick’s Day Parade, adding that "it is clear that the parade means as much to you in the community as it does to me."
Eight Republican-held Senate seats were flipped, bringing the Democratic caucus to 55 seats after Democrat Scott Colom was projected on Wednesday to win Mississippi’s Senate race.
"The NYPD will stop at nothing to get dangerous criminals off our streets," police said on X. Investigators located Rivera-Deleon in South Florida, where he had recently arrived and obtained employment at the restaurant, according to authorities.
"I'm heartbroken for the families of everyone impacted," Mayor Karen Bass said in a statement posted on X. "We will continue to provide updates as more information becomes available."
Trump signaled in the interview his willingness to "work a deal" for people who have been in the U.S. illegally for "10 and 15 years."
Also by Landon Mion
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 82 articles by Landon Mion →

Topics

FDA Fox News Digital Senate The White House the Food and Drug Administration

Subjects

FDA ORG · 7× Overton PERSON · 6× Biden PERSON · 4× Senate ORG · 4× The White House ORG · 4× Baptist PERSON · 3× Fox News Digital ORG · 1× Heidi Overton's PERSON · 1× Trump PERSON · 1× the Food and Drug Administration ORG · 1×

Narrative

In an interview with Fox News Digital, Erik Baptist, senior vice president of legal strategy at Susan B. Anthony Pro-Life America, said his group asked the Senate to hold up Overton’s confirmation until it received "firm commitments" from the administration on two fronts regarding abortion drug policy.
framing: assertive · carried by 1 article(s) · first seen 2026-11-20
"When I say anybody, we’ve seen news story after news story every week about men and other predators obtaining these drugs to coerce or poison women into taking them against their will.

Claims (48 extracted, 4 hedged)

A leading pro-life group said it opposed advancing Heidi Overton's nomination to lead the Food and Drug Administration without commitments from the Trump administration on abortion drug policy. asserted
it → lead → policy
The White House withdrew her nomination this week amid questions about her support in the Senate. asserted
House → withdraw → Senate
In an interview with Fox News Digital, Erik Baptist, senior vice president of legal strategy at Susan B. Anthony Pro-Life America, said his group asked the Senate to hold up Overton’s confirmation until it received "firm commitments" from the administration on two fronts regarding abortion drug policy. asserted
it → say → policy
Baptist said the group wants the next FDA nominee to commit to ending mail-order access to abortion drugs authorized under the Biden administration and changing how the agency studies the safety of those pills. asserted
agency → say → pills
"Right now, we’re seeing more abortions in this country than before the Supreme Court’s decision overturning Roe v. Wade," Baptist said. asserted
Baptist → see → Wade
"That’s precisely because of what the Biden FDA did to authorize mail-order abortion drugs. asserted
FDA → ’ → drugs
We’re seeing upwards of 15,000 abortion drugs and abortions occurring in pro-life states. asserted
drugs → see → states
Those states can’t meaningfully enforce their laws while this nationwide policy is in place." asserted
policy → enforce → place
"Under the Biden-era policy, anybody can obtain these drugs online and receive them through the mail," he continued. asserted
he → obtain → mail
"When I say anybody, we’ve seen news story after news story every week about men and other predators obtaining these drugs to coerce or poison women into taking them against their will. asserted
men → say → will
My question to this administration is: How many more women have to be poisoned or coerced with abortion drugs before you take action on this drug?" asserted
you → have → drug
Under the Biden administration, the FDA eliminated the in-person dispensing requirement for mifepristone, allowing it to be prescribed without an in-person visit by certified prescribers and dispensed by certified pharmacies through the mail. asserted
it → eliminate → mail
On the group's second point of concern, Baptist said the FDA needs to conduct a new study to show the safety — or lack thereof — of mifepristone. asserted
FDA → say → mifepristone
"The problem is that the study is significantly flawed," he said. asserted
he → flaw → ?
"It’s almost designed to fail and not lead to future changes to the drug regimen. asserted
It → design → regimen
We have asked for more robust data because significant information is currently lacking, including transparency into the agency’s methodology and an invitation for outside experts who have studied this drug over the last few decades. asserted
who → ask → decades
Everybody should support better data, more transparency and outside experts who can inform an agency that has never conducted such a study before," he added. asserted
he → support → study
Several pro-life groups and Republican lawmakers have urged the Trump administration to complete the FDA’s safety review of mifepristone and consider reinstating safeguards, while some have called for removing the drug from the market. asserted
some → urge → market
The FDA said the review is ongoing, with study results expected in December 2026 and a final report expected by March 2027. asserted
report → say → March
The White House pulled Overton’s nomination to lead the FDA earlier this week, one day before a Senate committee vote. asserted
House → pull → vote
President Donald Trump picked Overton, a physician and White House advisor, in August to succeed Marty Makary, who resigned from the position in May. uncertain
who → pick → May
Kyle Diamantas has led the agency in an acting capacity since Makary’s departure. asserted
Diamantas → lead → departure
Overton also previously served as vice chair and chief policy officer at the America First Policy Institute, a conservative think tank, where she criticized expanded access to abortion pills in a 2023 policy brief. asserted
she → serve → brief
The White House said Overton lacked the votes on Capitol Hill and pulled her nomination, although Sen. Bill Cassidy, chair of the Senate health committee, contended that he believed she could have been confirmed. uncertain
she → say → committee
"The White House abandoned a viable confirmation path for Dr. Overton. asserted
House → abandon → Overton
The WH said that this was because she did not have the votes to pass. asserted
she → say → votes
This was odd as I was having productive conversations with members," Cassidy, R-La., wrote on X. asserted
Cassidy → have → X.
"I believe she would have had the votes to pass out of committee and pass the full Senate." asserted
she → believe → Senate
Baptist said he did not know whether the White House was concerned about pro-life votes or other constituencies but thinks Cassidy "was making progress with the administration to secure the commitments we were seeking and asking the Senate to hold the administration accountable for." asserted
administration → say → Senate
Cassidy had criticized Overton for supporting Trump’s decision to recommend changes to the childhood vaccine schedule, but the senator said he had been convinced she was right for the job after she committed to "follow the science." asserted
she → criticize → science
She had appeared alongside Trump in the Oval Office as the president signed an executive order calling for changes to childhood vaccine recommendations, including a recommendation to administer measles, mumps and rubella vaccines separately once individual shots become available domestically. asserted
shots → appear → vaccines
Cassidy said at a September hearing that there was no scientific evidence for Trump’s suggestion that the combined shot could be "quite lethal" and warned the remark could discourage vaccination. uncertain
remark → say → vaccination
"Yes, senator, the MMR vaccine is safe and effective," Overton told Cassidy. asserted
Overton → tell → Cassidy
Pressed on what she would do if Trump asked her to disregard the FDA’s safety standards, Overton said she would give the president her best advice and follow the legal requirements for reviewing individual products. asserted
she → press → products
Sen. Maggie Hassan, D-N.H., asked Overton directly whether Trump was wrong. asserted
Trump → ask → Overton
Overton reiterated that the vaccine was safe and effective and called it the best tool available during the measles outbreak. asserted
vaccine → reiterate → outbreak
Sen. Ed Markey, D-Mass., questioned why she had not corrected Trump in the Oval Office. asserted
she → question → Office
"Why should we expect you to stand up to the president as FDA commissioner?" Markey asked. asserted
Markey → expect → commissioner
Baptist said he wants the next FDA commissioner to be somebody who "understands science" and has experience managing an agency. asserted
who → say → agency
"The FDA is a very large bureaucracy with multiple constituencies, so understanding how science is conducted and how drugs are approved will be essential to any successful candidate or nominee for the position," he said. asserted
he → understand → position
…and 8 more, not listed.
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support